论文部分内容阅读
乐托儿是治疗急、慢性腹泻的新型药物。但对肝源性腹泻的治疗尚无报道,我们对24例由肝病而致腹泻应用乐托儿进行治疗,取得较好的疗效,现小结于下。 临床资料 24例肝源性腹泻病人,均为我院传染科住院病人。男14例,女10例,年龄从20岁至60岁,平均年龄42岁。 用药方法 首日2粒/次,每日3次,以后1粒/次,每日3次,10日为1疗程。 疗效评价标准 1.显效:大便次数恢复发病前的排便次数,(?)
Nursery children is the treatment of acute and chronic new type of drug diarrhea. However, the treatment of liver-derived diarrhea has not been reported, we treated 24 cases of diarrhea caused by liver disease and treatment of children, achieved good results, is summarized in the next. Clinical data 24 patients with liver-derived diarrhea, inpatient department in our department of Infectious Diseases. 14 males and 10 females, aged from 20 to 60 years old, with an average age of 42 years. Medication on the first day of 2 / time, 3 times a day, after a / three times a day, 10 days for a course of treatment. Efficacy evaluation criteria 1. Markedly: stool frequency recovery before the onset of defecation, (?)